share_log

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Simeonidis Harry

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Simeonidis Harry

Intelligent Bio Solutions | 4：持股變動聲明-高管 Simeonidis Harry
美股SEC公告 ·  09/28 05:05

牛牛AI助理已提取核心訊息

Harry Simeonidis, the Chief Executive Officer of Intelligent Bio Solutions Inc. (INBS), was granted 40,000 shares of common stock on September 25, 2024. The transaction, which was completed on the same day, was a grant and did not involve any monetary transaction, as the shares were acquired at a price of $0.00. Following this transaction, Simeonidis's direct holdings in the company increased to a total of 40,408 shares of common stock.
Harry Simeonidis, the Chief Executive Officer of Intelligent Bio Solutions Inc. (INBS), was granted 40,000 shares of common stock on September 25, 2024. The transaction, which was completed on the same day, was a grant and did not involve any monetary transaction, as the shares were acquired at a price of $0.00. Following this transaction, Simeonidis's direct holdings in the company increased to a total of 40,408 shares of common stock.
Harry Simeonidis，智慧生物解決方案公司（INBS）首席執行官，於2024年9月25日被授予40,000股普通股。該交易於同一天完成，屬於授予行爲，並未涉及任何貨幣交易，因爲這些股票以0.00美元的價格獲得。在此次交易後，Simeonidis在公司的直接持股增加到總共40,408股普通股。
Harry Simeonidis，智慧生物解決方案公司（INBS）首席執行官，於2024年9月25日被授予40,000股普通股。該交易於同一天完成，屬於授予行爲，並未涉及任何貨幣交易，因爲這些股票以0.00美元的價格獲得。在此次交易後，Simeonidis在公司的直接持股增加到總共40,408股普通股。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間